Cognitive resilience and severe Alzheimer’s disease neuropathology
Aging Brain · 2023 · 3 · 100065
DOI: 10.1016/j.nbas.2023.100065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Brain, 2023. Verfasst von Narges Ahangari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Cognitive resilience in Alzheimer's disease (AD) can be defined as retention of high cognition despite presence of considerable cerebral AD lesions. We sought to identify factors associated with this phenomenon. Data were obtained from National Alzheimer's Coordinating Centre (NACC) dataset. Subjects with severe AD neuropathology, based on National Institute on Aging-Reagan (NIA-Reagan) criteria, no other primary neuropathology, and a ≤ 2-year interval between last follow-up and death were included. Mini-mental status examination score ≥ 24 was used as a proxy for normal cognition. In total, 654 cases were included; 59 (9%) were cognitively resilient. Multivariable logistic regression model showed that resilient participants were more educated, had a lower body mass index (BMI), were more likely to be lifetime/recent smoker or use an anticoagulant/antiplatelet agent, compared with cognitively impaired subjects. In addition to expected protective factors such as higher education and lower BMI, our results showed that smoking (especially recent smoking) and anticoagulant/antiplatelet consumption are associated with resilience to clinical cognitive expression of severe AD pathology. Pharmacological approaches using this information might be explored for clinical AD amelioration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
- Keenan Research Centre for Biomedical Science, The Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
- Department of Psychiatry, Faculty of Medicine, University of Toronto, ON, Canada.
- Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
- Division of Neurosurgery, Faculty of Medicine, University of Toronto, ON, Canada.
- Division of Pathology, Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON, Canada.
Zitieren
APA
Ahangari, N., Fischer, C. E., Schweizer, T. A., & Munoz, D. G. (2023). Cognitive resilience and severe Alzheimer’s disease neuropathology. Aging Brain, 3, 100065. https://doi.org/10.1016/j.nbas.2023.100065
Vancouver
Ahangari N, Fischer CE, Schweizer TA, Munoz DG. Cognitive resilience and severe Alzheimer’s disease neuropathology. Aging Brain. 2023;3:100065. doi:10.1016/j.nbas.2023.100065
BibTeX
@article{Ahangari2023,
author = {Ahangari, Narges and Fischer, Corinne E and Schweizer, Tom A and Munoz, David G},
title = {Cognitive resilience and severe Alzheimer’s disease neuropathology},
journal = {Aging Brain},
year = {2023},
volume = {3},
pages = {100065},
doi = {10.1016/j.nbas.2023.100065}
}
EUVIMED